Citius Pharmaceuticals, Inc.

CTXR·NASDAQ·$0.70Share Price as of 11/2·$8MMarket Cap as of 11/2

Financials

10-QQ3 ended 06/30/2608/14/26 10-QQ2 ended 03/31/2605/15/26 10-QQ1 ended 12/31/2502/13/26 10-K/AFY 202501/28/26 10-KFY 202512/23/25

Disclosures

8-KCurrent report10/26/26 8-KCurrent report08/21/26 8-KCurrent report08/14/26 8-KCurrent report08/05/26 8-KCurrent report06/01/26

Prospectuses and Registrations

S-3Shelf registration05/22/26 424B5Prospectus supplement04/24/26 424B5Prospectus supplement10/21/25 424B5Prospectus supplement06/11/25 424B5Prospectus supplement04/02/25

Proxies

DEF 14ADefinitive proxy02/24/26 DEFA14AAdditional proxy materials02/24/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25 PRE 14APreliminary proxy04/18/25

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)02/17/26 SC 13D/ABeneficial ownership (amended)12/17/25 SC 13GBeneficial ownership10/27/25 Form 4Insider transaction09/23/25

Other

UPLOADLetter from the SEC08/10/26 EFFECTRequest for effectiveness06/02/26 CORRESPCorrespondence with the SEC05/29/26 ARSAnnual report to shareholders02/24/26 ARSAnnual report to shareholders01/27/25